Connection

Paolo Maggi to Coronavirus Infections

Back to Details
This is a "connection" page, showing publications Paolo Maggi has written about Coronavirus Infections.
Paolo Maggi
Connection Strength
0.069
Coronavirus Infections
  1. Editorial - Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents. Eur Rev Med Pharmacol Sci. 2020 05; 24(10):5193-5194.
    View in: PubMed
    Score: 0.028
  2. Factors associated with hospital admission for COVID-19 in HIV patients. AIDS. 2020 11 01; 34(13):1983-1985.
    View in: PubMed
    Score: 0.007
  3. Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord. 2020 08 14; 20(1):373.
    View in: PubMed
    Score: 0.007
  4. Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy. J Am Heart Assoc. 2020 09; 9(17):e016948.
    View in: PubMed
    Score: 0.007
  5. Hyperglycaemia on admission to hospital and COVID-19. Diabetologia. 2020 11; 63(11):2486-2487.
    View in: PubMed
    Score: 0.007
  6. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab. 2020 10; 46(5):403-405.
    View in: PubMed
    Score: 0.007
  7. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes Care. 2020 07; 43(7):1408-1415.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.